BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2741229
Number of visits today
361
Number of downloads
2012819
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Liberelle M, Toulotte F, Renault N, Gelin M, Allemand F, Melnyk P, Guichou JF, Cotelle P. Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs. J Med Chem 2022. [PMID: 35389210 DOI: 10.1021/acs.jmedchem.2c00075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pobbati AV, Kumar R, Rubin BP, Hong W. Therapeutic targeting of TEAD transcription factors in cancer. Trends Biochem Sci 2023:S0968-0004(22)00333-4. [PMID: 36709077 DOI: 10.1016/j.tibs.2022.12.005] [Reference Citation Analysis]
2 Lou J, Lu Y, Cheng J, Zhou F, Yan Z, Zhang D, Meng X, Zhao Y. A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities. European Journal of Medicinal Chemistry 2022;243:114684. [DOI: 10.1016/j.ejmech.2022.114684] [Reference Citation Analysis]
3 Gridnev A, Maity S, Misra JR. Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1021823] [Reference Citation Analysis]
4 Zagiel B, Melnyk P, Cotelle P. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present). Expert Opin Ther Pat 2022;:1-14. [PMID: 35768160 DOI: 10.1080/13543776.2022.2096436] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345